Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 29, 2024
Reporting Period: Single event date (February 29, 2024)
Context: The filing discloses the commencement of non-deal road shows by company executives utilizing a new investor presentation.
Key Financial Metrics
This filing does not contain audited financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The document serves solely as a disclosure of a regulatory event and the furnishing of an exhibit.
Material Changes
No material changes to financial performance or operational status are reported in this document. The primary change is the initiation of a non-deal road show strategy effective February 29, 2024.
Guidance, Outlook, and Management Commentary
- Management Action: Executives began using the "February 2024 Investor Presentation" (Exhibit 99.1) in non-deal road shows.
- Availability: The presentation is available on the company website under the "Investor" tab.
- Legal Status of Information: The information in Item 7.01 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference into other SEC filings.
- Leadership: The report was signed by T. Ronan Kennedy, Interim Chief Executive Officer and Chief Financial Officer.
Investor Verification Checklist
- Review the "February 2024 Investor Presentation" (Exhibit 99.1) for specific financial projections or strategic updates not detailed in this 8-K.
- Verify the current status of the company's 8% Series A Cumulative Convertible Preferred Stock (YCBD PR A) listed on NYSE American.
- Confirm the role and tenure of T. Ronan Kennedy as Interim CEO and CFO.
- Check the company website (www.cbdmd.com) for the full text of the investor presentation referenced in the filing.